Moderate-to-severe atopic dermatitis
Conditions
Interventions
Group 1: Single assessment of patient satisfaction with current therapy and evaluation of eligibility for systemic treatment according to S3 guideline for adult atopic dermatitis.
Sponsors
Almirall Hermal GmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Moderate to severe atopic dermatitis = 18 years of age Current need for treatment with topical therapeutics (e.g., topical glucocorticoids or topical calcineurin inhibitors) and/or basic skin care and/or conventional systemic therapeutics (e.g., oral glucocorticoids or ciclosporin) Written informed consent for data collection and data processing
Exclusion criteria
Exclusion criteria: Currently treated with biologics or JAK inhibitors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Satisfaction with the current therapy (single assessment). | — |
Secondary
| Measure | Time frame |
|---|---|
| Description of demographics Documentation of current therapy For patients dissatisfied with their current therapy only: assessment of the proportion eligible for systemic treatment according to the S3 guideline. | — |
Countries
Germany
Contacts
Public ContactAfra Kempf
Almirall Hermal GmbH
Outcome results
None listed